An overview of randomised controlled trials of adjuvant chemotherapy in head and neck cancer

British Journal of Cancer

Volumn 71, Issue 1, 1995, Pages 83-91

  Munro, A J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Head and neck cancer; Overview; Randomised trials

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; FOLINIC ACID; HYDROCORTISONE; HYDROXYUREA; MERCAPTOPURINE; METHOTREXATE; METHYLPREDNISOLONE; VINCRISTINE;

ADJUVANT CHEMOTHERAPY; ARTICLE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HEAD CANCER; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; META ANALYSIS; NECK CANCER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK; STATISTICAL ANALYSIS;

CHEMOTHERAPY, ADJUVANT; HEAD AND NECK NEOPLASMS; HUMANS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 0028852938     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1995.17     Document Type: Article

References (65)

1. ANTMAN EM, LAU J, KUPELNICK B, MOSTELLER F AND CHALMERS TC. (1992). A comparison of results of meta-analyses of randomized control trials and the recommendations of clinical experts. JAMA, 268, 240-248.
2. CACHIN Y. (1978). Cancer of the head and neck. In Randomized Trials in Cancer: a Critical Review by Sites, MJ (ed.) pp. 331-338. Raven Press: New York.
3. DERSIMDFOLAN R AND LAIRD N. (1986). Meta-analysis in clinical trials. Controlled Clin. Trials, 7, 177-188.
4. DETSKY AS AND SACKETT DL. (1985). When was a ‘negative’ clinical trial big enough? How many patients you needed depends upon what you found. Arch. Int. Med., 145, 709-712.
5. DIMERY IW AND HONG WK. (1993). Overview of combined modality therapies for head and neck cancer. J. Natl Cancer Inst., 85, 95-111.
6. DODION P, ANDRY G AND BALIKDJIAN D. (1986). Head and Neck Cancer. In Randomized Trials in Cancer: a Critical Review by Sites, Staquet MJ and Slevin ML (eds) pp. 525-547. Raven Press: New York.
7. EARLY BREAST CANCER TRIALISTS’ COLLABORATIVE GROUP (1990). Treatment of Early Breast Cancer, Vol. 1, worldwide evidence 1985-1990. Oxford University Press: Oxford.
8. LAU J, ANTMAN EM, JIMENEZ-SILVA J, KUPELNICK B, MOSTELLER F AND CHALMERS TC. (1992). Cumulative metaanalysis of therapeutic trials for myocardial infarction. N. Engl. J. Med., 327, 248-254.
9. PETO J AND EASTON D. (1989). Cancer treatment trials - past failures, current progress and future prospects. Cancer Surv., 8, 511-533.
10. STELL PM. (1992). Adjuvant chemotherapy for head and neck cancer. Semin. Radiat. Oncol., 2, 195-205.
11. STELL PM AND RAWSON NSB. (1990). Adjuvant chemotherapy in head and neck cancer. Br. J. Cancer, 61, 779-787.
12. STEWART LA ANDPARMAR MKB. (1993). Meta-analysis of the literature or individual patient data: is there a difference? Lancet, 341, 418-422.
13. TANNOCK IF AND BROWMAN GP. (1986). Lack of evidence for a role of chemotherapy in the routine management of locally advanced head and neck cancer. J. Clin. Oncol., 4, 1121-1126.
14. TAYLOR SG. (1987). Why has so much chemotherapy done so litte in head and neck cancer? J. Clin. Oncol., 5, 1-3.
15. THE DEPARTMENT OF VETERANS AFFAIRS LARYNGEAL CANCER STUDY GROUP (1991). Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N. Engl. J. Med., 324, 1685-1690.
16. WITHERS HR, TAYLOR JMG ANDMACIEJEWSKI B. (1988). The hazard of accelerated tumor clonogen repopulation during radiotherapy. Acta Oncol., 27, 131-146.
17. ARCANGELI G, NERVI C, RIGHINI R, CRETON G, ALESSANDRA MIRRI M AND GUERRA A. (1983). Combined radiation and drugs: the effect of intra-arterial chemotherapy followed by radiotherapy in head and neck cancer. Radiother. Oncol., 1, 101-107.
18. BACHAUD J, DAVID J, BOUSSIN G AND DALY N. (1991). Combined postoperative radiotherapy and weekly cisplatin infusion for locally advanced squamous cell carcinoma of the head and neck: preliminary report of a randomized trial. Int. J. Radiat. Oncol. Biol. Phys., 20, 243-246.
19. BEZWODA WR, DEMOOR NG ANDDERM AN DP. (1979). Treatment of advanced head and neck cancer by means of radiation therapy plus chemotherapy - a randomized trial. Medical Pediatr. Oncol., 6, 353-358.
20. BITTER K. (1981). Postoperative chemotherapy versus postoperative Cobalt 60 radiation in patients with advanced oral carcinoma - report on a randomized study. Head Neck Surg., 3, 264.
21. BROWMAN GP, HODSON I, LEVINE MN, SATHYA J, RUSSELL R, CRIPPS C, EAPEN L, GIRARD A ANDPANETTA D. (1993). Placebo-controlled randomized trial of intravenous infusional 5-fluorouracil (FU) concurrent with standard radiotherapy (RT) in Stages III and IV head and neck cancer (HNC). ASCO Proc., 12, 277-891A.
22. BRUNIN F, RODRIGUEZ J, JAULERRY C, JOUVE M, PONTVERT D, POINT D, MOSSERI V, POUILLART P, ASSELAIN B, BRUGERE J AND BATAINI JP. (1989). Induction chemotherapy in advanced head and neck cancer. Preliminary results of a randomized study. Acta Oncol., 28, 61-65.
23. DOGGETT RLS, BAGSHAW MA AND KAPLAN HS. (1967). Combined therapy using chemotherapeutic agents and radiotherapy. In Modern Trends in Radiotherapy, Deeley TJ and Wood CAP (eds) pp. 107-131. Butterworths: London.
24. ESCHWEGE F, SANCHO-GARNIER H, GERARD JP, MADELAIN M, DESAULTY A, JORTAY A AND CACHIN Y. (1988). Ten year results of randomized trial comparing radiotherapy and concomitant bleomycin to radiotherapy alone in epidermoid carcinomas of the oropharynx: experience of the European Organization for the Research and Treatment of Cancer. Natl Cancer Instmonogr., 6, 275-278.
25. FAZEKAS JT, SOMMER C AND KRAMER S. (1980). Adjuvant intravenous methotrexate or definitive radiotherapy alone for advanced squamous cancers of the oral cavity, oropharynx, supraglottic larynx or hypopharynx. Concluding report of an RTOG randomozed trial on 638 patients. Int. J. Radiat. Oncol. Biol. Phys., 6, 533-541.
26. FLETCHER GH, SUIT HD, HOWE CD, SAMUELS M, JESSE RH AND VILLAREAL RU. (1963). Clinical method of testing radiation-sensitizing agents in squamous cell carcinoma. Cancer, 16, 355-363.
27. FU KK, PHILLIPS TL, SILVERBERG IJ, JACOBS C, GOFFINET DR, CHUN C, FRIEDMAN MA, KOHLER M, MCWHIRTER K AND CARTER SK. (1987). Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of Northern California Oncology Group randomized trial. J. Clin. Oncol., 5, 1410-1418.
28. GOLLIN FF, ANSFIELD FJ, BRANDENBURG JH, RAMIREZ G AND VERMUND H. (1972). Combined therapy in advanced head and neck cancer: a randomized study. Am. J. Roentgenol. Radium Ther. Nucl. Med., 114, 83-88.
29. GUPTA NK, POINTON RCS AND WILKINSON PM. (1987). A randomized clinical trail to contrast radiotherapy with radiotherapy and methotrexate given synchronously in head and neck cancer. Clin. Radiol., 38, 575-581.
30. HEAD AND NECK CONTRACTS PROGRAM (1987). Adjuvant chemotherapy for advanced head and neck squamous carcinoma. Final report of the head and neck contracts program. Cancer, 60, 301-310.
31. HOLOYE PY, GROSSMAN TW, TOOHILL RJ, KUN LE, BYHARDT RW, DUNCAVAGE JA, TEPLIN RW, RITCH PS, HOFFMAN RG AND MALIN TA. (1985). Randomized study of adjuvant chemotherapy for head and neck cancer. Otolaryngol. Head Neck Surg., 93, 712-717.
32. HUSSEY DHAND ABRAMS JP. (1975). Combined therapy in advanced head and neck cancer: hydroxyurea and radiotherapy. Prog. Clin. Cancer, 6, 79-86.
33. JAULERRY C, RODRIGUEZ J, BRUNIN F, JOUVE M, MOSSERI V, POINT D, PONTVERT D, VALIDIRE P, ZAFRANI B, BLASZKA B, ASSELAIN B, POUILLART P AND BRUGERE J. (1992). Induction chemotherapy in advanced head and neck tumors: results of two randomized trials. Int. J. Radiat. Oncol. Biol. Phys., 23, 483-489.
34. JORTAY A, DEMARD F, DALESIO O, BLANCHET C, DESAULTY A, GEHANNO C, LEFEBRE JL, MOLINARI R, TRAISSAC L, DEHESDIN M & KIRKPATRICK A. (1990). A randomized EORTC study on the effect of preoperative polychemotherapy in pyriform sinus carcinoma treated by pharyngolaryngectomy and irradiation: results from 5 to 10 years. Acta. Chir. Belg., 90, 115-122.
35. KAPSTAD B, BANG G, RENNAES S AND DAHLER A. (1978). Combined preoperative treatment with cobalt and bleomycin in patients with head and neck carcinoma - a controlled clinical study. Int. J. Radiat. Oncol. Biol. Phys., 4, 85-89.
36. KEANE TJ, CUMMINGS BJ, O’SULLIVAN B, PAYNE D, RAWLIN-SON E, MACKENZIE R, DANJOUX C AND HODSON I. (1993). A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma. Int. J. Radiat. Oncol. Biol. Phys., 25, 613-618.
37. KEEGAN P, PILLSBURY HR, WEISSLER M, FRY T AND ROSE-MAN JR. (1988). Simultaneous cisplatinum-5fu and radiotherapy vs radiotherapy alone in advanced squamous carcinoma of the head and neck. ASCO Proc., 7, 157-609A.
38. KLIGERMAN MM, HELLMAN S, VONES SEN CF AND BERTINO JR. (1966). Sequential chemotherapy and radiotherapy: preliminary results of a clinical trial with methotrexate in head and neck cancer. Radiology, 86, 247-250.
39. KNOWLTON AH, PERCAPIO B, BOBROW S AND FISHER JJ. (1975). Methotrexate and radiation therapy in the treatment of advanced head and neck tumors. Radiology, 116, 709-712.
40. LARAMORE GE, SCOTT CB, AL SARRAF M, HASELOW RE, ERVIN TJ, WHEELER R, JACOBS JR, SCHULLER DE, GAH-BAUER RA, SCHWADE JG AND CAMPBELL BH. (1992). Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: report on intergroup study 0034. Int. J. Radiat. Oncol. Biol. Phys., 23, 705-713.
41. LO TCM, WILEY AL, ANSFIELD FJ, BRANDENDBURG JH, DAVIS HL, GOLLIN FF, JONSON RO, RAMIREZ G AND VERMUND H. (1976). Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized study. Am. J. Roentgenol. Radium Ther. Nucl. Med., 126, 229-235.
42. LUSTIG RA, DEMARE PA AND KRAMER S. (1976). Adjuvant methotrexate in the radiotherapeutic management of advanced tumors of the head and neck. Cancer, 37, 2703-2708.
43. MARTIN M, HAZAN A, VERGNES L, PEYTRAL C, MAZERON JJ, SENECHAUT JP, LELLFSIVRE G AND PEYNEGRE R. (1990). Randomized study of 5 Fluorouracil and cis-platin as neoadjuvant therapy in head and neck cancer: a preliminary report. Int. J. Radiat. Oncol. Biol. Phys., 19, 973-975.
44. MARTIN M, LEIEVRE G, GEHANNO C, DEPONDT J, GUERRIER B, PEYTRAL C, HAZAN A, DUBREUIL P, MARGOTTON A AND PELLAECOSSET B. (1992). Induction carboplatin (CBDCA) and 5-fluorouracil (5-FU) treatment versus no chemotherapy before locoregional treatment for oro and pharyngolaryngeal cancers: preliminary results of a randomized study. ASCO Proc., 11, 240.
45. MARTIN M, MAZERON JJ, BRUN B, VERGNES L, LELIEVRE G, FEUILLADE F, JUVANON JM, HADDAD E, SOUCHAL DELACOUR I, PEYNEGRE R AND PIERQUIN B. (1988). Neoadjuvant polychemotherapy of head and neck cancer: results of a randomized study. ASCO Proc., 7, 152.
46. MERLANO M, VITALE V, ROSSO R, BENASSO M, CORVO R, CAVALLARI M, SANGUINETI G, BACIGALUPO A, BADELLINO F, MARGARINO G, BREMA F AND PASTORINO G. (1992). Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy. N. Engl. J. Med., 327, 1115-1121.
47. NISSENBAUM M, BROWDE S, BEZWODA WR, DEMOOR NG AND DERMAN DP. (1984). Treatment of advanced head and neck cancer: multiple daily dose fractionated radiation therapy and sequential multimodal treatment approach. Med. Pediatr. Oncol., 12, 204-208.
48. PACCAGNELLA A, ORLANDO A, MARCHIORI C, ZORAT PL, CHIARION-SILENI V, JIRILLO A, TOMIO L, FILA G, FEDE A, BARI M, GAVA A, PAPPAGALLO GL AND FIORENTINO MV. (1993). A phase III trial of neoadjuvant chemotherapy in head and neck cancer. ASCO Proc., 12, 894A.
49. PEARLMAN NW, JOHNSON FB, BRAUN TJ, KENNAUGH RC, SPOFFORD BF, BORLASE BC, MEYER TJ, STIEG MANN GV AND MEYERS AD. (1985). A prospective study of preoperative chemotherapy and split-course irradiation for locally advanced or recurrent oral-pharyngeal squamous carcinoma. Am. J. Clin. Oncol. (CCT), 8, 490 -496.
50. PETROVICH Z. BLOCK J, KUISK H, MACKINTOSH R, CASCIATO D, JOSE L AND BARTON R. (1981). A randomized comparison of radiotherapy with a radiotherapy- chemotherapy combination in stage IV carcinoma of the head and neck. Cancer, 47, 2259 - 2264.
51. RENTSCHLER RE, WILBUR DW, PETTI GH, CHONKICH GD, HILLIARD DA, CAMACHO ES AND THORPE RB. (1987). Adjuvant methotrexate escalated to toxicity for resectable Stage III and IV squamous head and neck carcinomas — a prospective randomized study. J. Clin. Oncol., 5, 278-285.
52. RICHARD JM, SANCHO H, LEPINTRE Y, RODARY J AND PIER-QUIN B. (1974). Intra-arterial methotrexate chemotherapy and telecobalt therapy in cancer of the oral cavity and oropharynx. Cancer, 34, 491-496.
53. RICHARDS GJ AND CHAMBERS RG. (1969). Hydroxyurea: a radiosensitizer in the treatment of neoplasms of the head and neck. Am. J. Roentgenol. Radium Ther. Nucl. Med., 105, 555-565.
54. ROSSI A, MOLINARI R, BORACCHI P, DEL VECCHIO M, MARUBINI E, NAVA M, MORANDI L, ZUCALI R, PILOTTI S, GRANDI C, AMBROSINI G, CELLINI N, CHIAVACCI A, COLOMBO A, DAL FIOR S, DE MARIA D, FELCI U, GABRIELE P, LADDAGA M, MAGNO L, MARZIANO C, OLMI P, PRINO A RONCORONI L, TORRETTA A, ZAMPI G, ZORAT PL AND DE PALO G. (1988). Adjuvant chemotherapy with Vincristine, Cyclophosphamide and Doxorubicin after radiotherapy in loco- regional nasopharyngeal cancer: results of a 4-year multicenter randomized study. J. Clin. Oncol., 6, 1401-1410.
55. SANCHIZ F, MILLA A TORNER J, BONET F, ARTOLA N, CAR- RENO L, MOYA LM, RIERA D, RIPOL S AND CIRERA L. (1990). Single fraction per day versus two fractions per day versus radiochemotherapy in the treatment of head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 19, 1347-1350.
56. SCHULLER DE, METCH B. MATTOX D, STEIN DW AND MCCRAKEN JD. (1988). Preoperative chemotherapy in advanced resectable head and neck cancer: final report of the southwest oncology group. Laryngoscope, 98, 1205-1211.
57. SHANTA V AND KRISHNAMURTHI S. (1980). Combined bleomycin and radiotherapy in oral cancer. Clin. Radiol 31, 617-620.
58. SHIGEMATSU Y, FUCHIHATA H, MAKINO T AND INOUE T. (1973). Radiotherapy with reduced fraction in head and neck cancer with special reference to hyperbaric oxygen radiotherapy in maxillary sinus carcinoma (a controlled study). In Fraction Size in Radiobiology and Radiotherapy, Sugahara T, Scott OCA and Revesz L (eds) pp. 180-187. Wilhams & Wilkins: Baltimore.
59. SIODLAK MZ, DALBY JE, BRADLEY PJ, CAMPBELL JB, STRICKLAND P, FRASER JG, WILLATT DJ, FLOOD LM AND STELL PM. (1989). Induction VBM plus radiotherapy versus radiotherapy alone for advanced head and neck cancer: long term results. Clin. Otolaryngol., 14, 17-22.
60. STOLWUK C, WAGENER DJT, VAN DEN BROEK P, LEVENDAG PC, KAZEM I, BRUASET I AND DE MULDER PHM. (1985). Randomized neo-adjuvant chemotherapy trial for advanced head and neck cancer. head and neck cancer. Arch. Otolaryngol. Head Neck Surg., 113, 758-761.
61. VERMUND H, KAALHUS O, WINTHER F, TRAUSJO J, THORUD E AND ARANG R. (1985). Bleomycin and radiation therapy in squamous cell carcinoma of the upper aero-digestive tract: a phase III clinical trial. Int. J. Radiat. Oncol. Biol. Phvs., 11, 1877-1886.
62. VON ESSEN CF, JOSEPH LBM, SIMON GT, SINGH AD AND SINGH SP. (1968). Sequential chemotherapy and radiation therapy of buccal mucosa carcinoma in South India. Am. J. Roentgenol. Radium Ther. Nucl. Med., 102, 530- 540.
63. WEISSBERG JB, SON YH, PAPAC RJ, SASAKI C, FISCHER DB, LAWRENCE R, ROCKWELL S, SARTORELLI AC AND FISCHER JJ. (1989). Randomized clinical trial of Mitomycin C as an adjunct to radiation therapy in head and neck cancer. Int. J. Radiat. Oncol. Biol. Phys., 17, 3-9.
64. STEFANI S AND CHUNG TS. (1980). Hydroxyurea and radiotherapy in head and neck cancer - long term results of a double blind prospective study. Int. J. Radiat. Oncol. Biol. Phvs., 6, 1398-190A.
65. ERVIN TJ, CLARK JR, WEICHSELBAUM RR, FALLON BG, MILLER D, FABIAN RL, POSNER MR, NORRIS CM, TUTTLE SA, SCHOENFELD DA, PRICE KN AND FREI E. (1987). An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous-cell carcinoma of the head and neck. J. Clin. Oncol., 5, 10-20.